Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C548651 |
2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester |
2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in increased expression of GULP1 mRNA | increases expression | 19933214
|
D000111 |
Acetylcysteine |
Acetylcysteine results in decreased expression of GULP1 mRNA | decreases expression | 16084531
|
D016604 |
Aflatoxin B1 |
Aflatoxin B1 affects the expression of GULP1 protein | affects expression | 20106945
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of GULP1 mRNA | decreases expression | 20713471
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of GULP1 mRNA | decreases expression | 20018196
|
D020122 |
tert-Butylhydroperoxide |
tert-Butylhydroperoxide results in decreased expression of GULP1 mRNA | decreases expression | 15336504
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride affects the expression of GULP1 mRNA | affects expression | 17484886
|
D016572 |
Cyclosporine |
Cyclosporine results in increased expression of GULP1 mRNA | increases expression | 20106945
|
D004317 |
Doxorubicin |
Doxorubicin results in decreased expression of GULP1 mRNA | decreases expression | 16001973
|
C045651 |
epigallocatechin gallate |
epigallocatechin gallate results in decreased expression of GULP1 mRNA | decreases expression | 16084531
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of GULP1 mRNA | affects binding|decreases expression|increases activity | 19710929
|
D012643 |
Selenium |
Selenium results in decreased expression of GULP1 mRNA | decreases expression | 19244175
|
D018038 |
Sodium Selenite |
Sodium Selenite results in decreased expression of GULP1 mRNA | decreases expression | 18175754
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of GULP1 mRNA | increases expression | 19933214
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
2.93 | 15322242 11752688 14514962 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.17 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
4.50 | 20127859 20464547 |
MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
4.50 | 17418594 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
2.68 | 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
10.18 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
10.18 | 16835633 |
MESH:D000419 |
Albuminuria |
|
Doxorubicin |
4.61 | 21441931 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.00 | 11748828 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
4.15 | 19183758 |
MESH:D001249 |
Asthma |
|
epigallocatechin gallate |
3.40 | 16516891 |
MESH:D001327 |
Autoimmune Diseases |
|
epigallocatechin gallate |
5.14 | 19761891 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
8.95 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
8.95 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.89 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.80 | 15746008 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
4.80 | 14601052 |
MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
3.86 | 17150277 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
1.85 | 17474063 20146248 |
MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
1.85 | 16115903 18695136 17369602 16096432 15692762 18628466 16595493 16264153 15993339 19526202 18234424 15136595 17983394 15939500 16826403 15567936 16935488 18382427 15634643 17426702 15668708 11325840 16322301 15994142 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.85 | 20435547 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Carbon Tetrachloride |
3.85 | 10355542 15721981 16124888 15700767 3786805 16227642 16050911 15673190 16192424 18705752 16097048 16011737 |
MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
4.91 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.84 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
4.70 | 12907637 21507988 12619106 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Carbon Tetrachloride |
4.70 | 18788625 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
4.70 | 17876044 18059187 16234567 16023760 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
3.18 | 16201981 1485588 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Acetylcysteine |
7.76 | 17015178 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
7.76 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
7.76 | 6189445 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.39 | 18850075 18670907 16120746 |
MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
3.56 | 16242529 17519947 17928571 18627295 16612575 16109756 16952015 17308081 17974986 15505089 15792986 16651473 16455267 16731534 15811867 16269455 16278810 17329180 17007740 17351982 17924179 15476868 17382496 16364871 17131338 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
2.96 | 17334414 16243910 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
11.50 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Acetylcysteine |
11.50 | 18226522 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
11.50 | 12371664 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.21 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
7.89 | 19486331 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
7.89 | 19176532 |
MESH:D019457 |
Chromosome Breakage |
|
Sodium Selenite |
4.82 | 15894690 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.12 | 12621046 8697196 15668235 15340226 16354765 |
MESH:D003092 |
Colitis |
|
Selenium |
3.85 | 17936198 |
MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
2.14 | 18802399 18259882 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.11 | 17141729 14669216 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.26 | 15322242 10048152 20055451 |
MESH:D003550 |
Cystic Fibrosis |
|
Acetylcysteine |
4.42 | 19747007 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.45 | 18249437 |
MESH:D003920 |
Diabetes Mellitus |
|
Sodium Selenite |
3.82 | 16285004 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
epigallocatechin gallate |
4.66 | 16988119 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
4.66 | 17107852 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetylcysteine |
15.49 | 11287661 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbon Tetrachloride |
15.49 | 3732212 17522070 7179309 16227642 11566570 7440962 19336974 15968718 3786805 2869522 10092053 9327722 6884620 19085960 7120509 16177239 15027814 4309450 6623471 21278145 15998439 10915739 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
15.49 | 17416283 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Selenium |
15.49 | 15131321 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Sodium Selenite |
15.49 | 15131321 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
15.49 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
8.24 | 18602426 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
8.24 | 11462148 |
MESH:D004487 |
Edema |
|
pirinixic acid |
6.72 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
6.72 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.00 | 15322242 16714409 18230668 |
MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
3.48 | 17359293 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.07 | 9294722 10568697 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
5.25 | 18037988 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
4.39 | 20426865 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
4.39 | 16530937 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.05 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Carbon Tetrachloride |
13.37 | 15959796 16239168 12631006 16045604 12795759 19224547 61145 17595544 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
13.37 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
13.37 | 19236843 20131406 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.53 | 11858732 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
4.67 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Carbon Tetrachloride |
15.15 | 18705752 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
15.15 | 12639820 12168785 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
15.15 | 20067830 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.30 | 8708960 |
MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
3.38 | 17150277 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.69 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
3.56 | 15692506 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
6.54 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
6.54 | 10048152 11294989 |
MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
3.52 | 16330681 16244372 12587719 16495754 16144979 17875725 18674790 18006777 16244371 16879835 17888722 14766674 16707910 |
MESH:D006333 |
Heart Failure |
|
Doxorubicin |
12.00 | 17481944 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
12.00 | 20558911 |
MESH:D006333 |
Heart Failure |
|
Selenium |
12.00 | 17162251 |
MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
3.95 | 15692506 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.50 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.39 | 11000095 |
MESH:D006505 |
Hepatitis |
|
Carbon Tetrachloride |
3.66 | 19110552 19900420 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
8.50 | 16221962 19176532 19772884 18467677 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
8.50 | 15340226 12621046 16120746 |
MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
3.45 | 18501091 17606976 15147373 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.14 | 8697196 15340226 16959395 18606429 16354765 |
MESH:D006932 |
Hyperbilirubinemia |
|
Carbon Tetrachloride |
4.61 | 16899240 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.23 | 20558911 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
5.01 | 10903974 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
5.01 | 18670907 18850075 |
MESH:D006975 |
Hypertension, Portal |
|
Carbon Tetrachloride |
4.16 | 15338365 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
1.88 | 12200463 12878042 |
MESH:D007251 |
Influenza, Human |
|
Selenium |
4.29 | 16624496 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
7.42 | 16306350 |
MESH:D007333 |
Insulin Resistance |
|
Sodium Selenite |
7.42 | 14714311 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.39 | 16580747 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.54 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
6.21 | 8314463 10903974 18776723 |
MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
6.21 | 16775033 15369732 15699352 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
10.17 | 16707910 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Selenium |
10.17 | 16518626 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
2.78 | 12371664 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
5.25 | 16085563 |
MESH:D008103 |
Liver Cirrhosis |
|
Carbon Tetrachloride |
2.83 | 11408273 16943688 17157831 11903743 17174718 16239168 16221502 21278145 17334410 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Carbon Tetrachloride |
6.82 | 18395095 17698563 14724832 12649538 14716833 17805973 18705752 18210741 11481614 17557913 16136751 12898905 16033810 17721639 16097048 15730626 14748882 17823541 18420326 18472094 17900296 18472332 20821823 17708605 12609069 12389079 15057751 12546737 17944888 17481882 18263696 18395914 15052691 16015684 17640975 18251166 17565644 17869086 17631135 15338365 12632512 14512876 16192424 14620537 17525996 15931870 17766677 14716496 15123356 18376398 16027843 15673190 15362042 15818738 18339082 17922224 18156304 17761835 12445421 18054572 18187930 10355542 16011737 18006644 15650968 12445418 15893842 12666154 12586293 15370692 12667390 16248980 12741479 16638106 18481824 18277467 18429990 18279442 13678700 17714472 18166357 15925388 15959796 18412020 18205269 12632514 15876570 17976157 18418968 16116963 15996030 12958196 18317297 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
6.82 | 16439617 16595196 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
epigallocatechin gallate |
6.82 | 17481882 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
6.82 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
6.82 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Carbon Tetrachloride |
2.09 | 17285989 15830285 16964402 16246199 15720792 |
MESH:D017093 |
Liver Failure |
|
Carbon Tetrachloride |
4.24 | 15123358 |
MESH:D017114 |
Liver Failure, Acute |
|
Carbon Tetrachloride |
3.74 | 16899240 14706259 |
MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
14.44 | 2125692 15890375 9163691 18177683 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
14.44 | 21137059 20195826 |
MESH:D008113 |
Liver Neoplasms |
|
Carbon Tetrachloride |
14.44 | 19294768 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
14.44 | 16377806 20007298 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
14.44 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
14.41 | 8603461 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Carbon Tetrachloride |
14.41 | 12014681 15583823 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
14.41 | 17085340 16842330 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
14.41 | 12151625 |
MESH:D008171 |
Lung Diseases |
|
Acetylcysteine |
4.09 | 12815614 |
MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
4.89 | 14755239 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
4.89 | 18816296 17053015 18569708 6695378 18520028 20064080 20464547 20135361 20869020 |
MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
4.89 | 17418594 6189445 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
4.89 | 11884234 19555203 |
MESH:D008223 |
Lymphoma |
|
Doxorubicin |
3.50 | 16098063 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Sodium Selenite |
4.12 | 14737004 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
3.83 | 17654614 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
4.64 | 15621674 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
6.31 | 15458769 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Selenium |
6.31 | 15318939 |
MESH:D008545 |
Melanoma |
|
Doxorubicin |
3.85 | 16827129 |
MESH:D008545 |
Melanoma |
|
epigallocatechin gallate |
3.85 | 11746506 17992120 |
MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
6.35 | 17638057 |
MESH:D008654 |
Mesothelioma |
|
Selenium |
6.35 | 15107826 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.88 | 16801185 |
MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
4.55 | 15792986 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.23 | 16381670 |
MESH:D052016 |
Mucositis |
|
Doxorubicin |
4.87 | 17415656 |
MESH:D009134 |
Muscular Atrophy, Spinal |
|
epigallocatechin gallate |
5.57 | 17962980 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.58 | 16239165 |
MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
5.78 | 19429709 15857846 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
5.78 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.06 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
2.99 | 16411023 |
MESH:D009362 |
Neoplasm Metastasis |
|
Acetylcysteine |
6.32 | 14720322 |
MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
6.32 | 18259882 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
4.90 | 11141357 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
4.90 | 17405874 |
MESH:D009401 |
Nephrosis |
|
Doxorubicin |
4.84 | 16899518 16636307 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.54 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
9.46 | 19348381 18481113 |
MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
9.46 | 15640375 16889571 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.28 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
Acetylcysteine |
4.06 | 19446573 |
MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
3.29 | 15555623 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.82 | 20558911 |
MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
4.16 | 15930896 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.35 | 12520081 |
MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
5.25 | 17983394 |
MESH:D010954 |
Plasmacytoma |
|
Selenium |
4.99 | 15087411 |
MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
5.25 | 17638057 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.62 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.27 | 12371664 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.27 | 11896295 11118676 11399792 11222880 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
2.59 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
2.59 | 15897917 16888761 18437689 15749863 16729912 16868541 |
MESH:D011471 |
Prostatic Neoplasms |
|
Sodium Selenite |
2.59 | 18760546 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.24 | 16882103 |
MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
4.29 | 17922066 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.41 | 19058328 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Acetylcysteine |
4.58 | 12210543 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.90 | 18990726 |
MESH:D012509 |
Sarcoma |
|
Doxorubicin |
4.04 | 18313854 16767912 17710206 15625365 17203757 15675481 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
4.31 | 14601052 16326096 |
MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
4.87 | 17846226 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
13.77 | 19755658 10029692 |
MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
13.77 | 15692506 |
MESH:D012878 |
Skin Neoplasms |
|
tert-Butylhydroperoxide |
13.77 | 8532709 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
13.77 | 16192470 |
MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
4.64 | 15625365 17203757 16767912 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
1.56 | 20155912 2093021 |
MESH:D013276 |
Stomach Ulcer |
|
Acetylcysteine |
4.05 | 17918041 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.00 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
3.41 | 17909728 16010429 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
5.21 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
5.21 | 17653716 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.08 | 1336536 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.69 | 12125929 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
4.29 | 17678736 17334414 17638931 16364871 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.35 | 15886252 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.54 | 17120751 |